[Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].

Abstract

Thirty lepromatous patients were treated during 3 months. If clinical condition was notably improved, the bacillary index and the morphologic index remained almost un-changed and the histo-pathological features, advanced concurrently to the clinic aspects.

• Authors: M Colin, E de Montaigne
• Journal: Medecine tropicale : revue du Corps de sante colonial (Med Trop (Mars)) 1980 Mar-Apr Vol. 40 Issue 2 Pg. 157-9 ISSN: 0025-682X [Print] France
• Vernacular Title: Traitement de la maladie de Hansen lépromateuse par l'association de rifampicine et d'isoprodian.
• PMID: 6991851 (Publication Type: English Abstract, Journal Article)

Chemical References

• Drug Combinations
• Isonicotinic Acids
• Leprostatic Agents
• isoprodian
• Prothionamide
• Dapsone
• Isoniazid
• Rifampin

Topics

• Dapsone (therapeutic use)
• Drug Combinations (therapeutic use)
• Drug Therapy, Combination
• Humans
• Isoniazid (therapeutic use)
• Isonicotinic Acids (therapeutic use)
• Leprostatic Agents (therapeutic use)
• Leprosy (drug therapy, microbiology, pathology)
• Mycobacterium leprae (drug effects)
• Prothionamide (therapeutic use)
• Rifampin (therapeutic use)
• Skin (pathology)